With deep job cuts at the FDA, inspectors say the ongoing strain could compromise policing an industry spread across more than 90 countries.

“Things will be missed, we are going to have a lot less safe drugs,” a former inspector said.
propublica.org/article/fda-cut…

#News #FDA #Drugs #Safety #Health #Medicine #Government

FDA Cuts Will Limit Scrutiny of Troubled Foreign Drug Factories, Inspectors Say

Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked with rooting out dangerous manufacturing practices.

^ProPublica

One former senior official called it “mind-boggling” that the Drug Enforcement Administration is “just getting orders saying, ‘This is what Stephen Miller wants and you’ve got to give it to us.’”

propublica.org/article/stephen…

#News #Trump #WhiteHouse #Crime #Drugs #DHS #FBI #StephenMiller

A New Trump Plan Gives DHS and the White House Greater Influence in the Fight Against Organized Crime

Internal documents and interviews show that an overhaul led by Stephen Miller would scale back prosecutors’ control over investigations.

^ProPublica

The FDA allowed into the United States at least 150 drugs or their ingredients made at banned factories that were found to have mold, foul water, dirty labs or fraudulent testing protocols.

Key takeaways of our investigation:
propublica.org/article/fda-dru…

#News #FDA #Drugs #Safety #Health #Medicine #Pharma #Science #Lab

How the FDA Let Medications From Banned Foreign Factories Into the U.S.

ProPublica spent 14 months investigating the FDA’s oversight of foreign drugmakers that send medications to the U.S. These are the key takeaways.

^ProPublica

ProPublica has sued the FDA, accusing the agency of withholding information about the safety and availability of generic drugs critical to millions of Americans.
propublica.org/article/propubl…

#Journalism #Law #FDA #Drugs #Safety #Health #Medicine

ProPublica Sued the FDA for Withholding Records About Drug Safety

The agency declined to quickly release documents that would identify drugs made at some of the most troubled foreign factories. The request was part of ProPublica’s ongoing investigation into the safety of America’s generic drug supply.

^ProPublica